EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Spatial Acid‐Associated Niches Inform Irinotecan‐Based DEB ‐ TACE in Colorectal Liver Metastases: A Multicentre Randomized Trial

Siyuan Weng, Wenwei Hu, Jianfei Tu, Junqing Xi iD, Hongbing Shi, Minhua Wu, Jianhui Huang, Haidong Zhu iD, Zhengqiang Yang iD

Liver International · 2026-12 · 46 (12)

DOI: 10.1111/liv.70931 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 02.11.2026. Verfasst von Siyuan Weng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Therapy, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical…. Hauptthemen laut MEDLINE: Irinotecan, Liver Neoplasms, Colorectal Neoplasms, Chemoembolization, Therapeutic. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Drug‐eluting bead transarterial chemoembolisation (DEB‐TACE), particularly irinotecan‐based regimens, has emerged as a liver‐directed option for unresectable colorectal liver metastases (CRLM), yet how metastatic‐niche biology relates to local drug delivery remains poorly defined.

Methods

We integrated bulk, single‐cell, and spatial transcriptomics with spatial pharmacogenomic inference (SpaDR) to characterize acid‐associated states in CRLM and predict regional drug sensitivity, compared pH‐dependent irinotecan release of UniPearls and HepaSphere microspheres, and evaluated both platforms in a four‐centre randomised trial of 35 patients with unresectable CRLM.

Results

CRLM exhibited an acid‐associated transcriptional phenotype (AcidScore), partly shared with TACE‐nonresponder hepatocellular carcinoma and associated with shorter overall survival in CRLM. This phenotype localized to a spatially organized niche of SPP1 + macrophages and cancer‐associated fibroblasts, in which AcidScore and malignant epithelium increased with distance from the vasculature, consistent with a putative stromal‐metabolic barrier. SpaDR linked higher AcidScore to lower predicted SN‐38 IC 50 in most sections, identifying candidate sensitivity beyond this interface. Accordingly, UniPearls released more irinotecan than HepaSphere within 24 h at every pH tested, with the largest difference at pH 5.7. Disease control after the final DEB‐TACE was higher with UniPearls (per‐protocol, 100% vs. 68.75%; p = 0.018), as was final technical success (100% vs. 76.47%; p = 0.046); objective response and adverse‐event frequencies were similar. Non‐inferiority held across sensitivity analyses, whereas superiority was sensitive to missing‐outcome assumptions.

Conclusions

Acid‐associated spatial organization and drug‐response predictions provide a rationale for local irinotecan delivery in CRLM. These findings support further evaluation of UniPearls‐based DEB‐TACE and prospective biomarker‐stratified studies linking niche biology to clinical benefit. Trial Registration NCT06021015. Registered 27 August 2023, https://clinicaltrials.gov/study/NCT06021015

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IrinotecanLiver NeoplasmsColorectal NeoplasmsChemoembolization, TherapeuticHumansFemaleMaleTumor MicroenvironmentMiddle AgedMicrospheresAgedHydrogen-Ion Concentration

Stichwörter der Autor:innen

chemoembolisationirinotecanliver neoplasmsmicrospherestumour microenvironment

Substanzen

Irinotecan

Autor:innen und Institutionen

  • Department of Interventional Therapy, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Oncology, The First People's Hospital of Changzhou, Changzhou, China.
  • Cancer Centre, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui, China.
  • Key Laboratory of Comprehensive Diagnosis and Treatment for Thoracic and Abdominal Tumors, Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
  • Centre of Interventional Radiology & Vascular Surgery, Department of Radiology, Medical School, Zhongda Hospital, Southeast University, Nanjing, China.

ORCID-Profile: Junqing Xi, Haidong Zhu, Zhengqiang Yang

Zitieren

APA

Weng, S., Hu, W., Tu, J., Xi, J., Shi, H., Wu, M., Huang, J., Zhu, H., & Yang, Z. (2026). Spatial Acid‐Associated Niches Inform Irinotecan‐Based DEB ‐ TACE in Colorectal Liver Metastases: A Multicentre Randomized Trial. Liver International, 46(12). https://doi.org/10.1111/liv.70931

Vancouver

Weng S, Hu W, Tu J, Xi J, Shi H, Wu M, et al. Spatial Acid‐Associated Niches Inform Irinotecan‐Based DEB ‐ TACE in Colorectal Liver Metastases: A Multicentre Randomized Trial. Liver International. 2026;46(12). doi:10.1111/liv.70931

BibTeX
@article{Weng2026,
  author = {Weng, Siyuan and Hu, Wenwei and Tu, Jianfei and Xi, Junqing and Shi, Hongbing and Wu, Minhua and Huang, Jianhui and Zhu, Haidong and Yang, Zhengqiang},
  title = {Spatial Acid‐Associated Niches Inform Irinotecan‐Based DEB ‐ TACE in Colorectal Liver Metastases: A Multicentre Randomized Trial},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {12},
  doi = {10.1111/liv.70931}
}
Kostenlos starten →